Increasing prevalence of different sleeping disorders fuels the Global Narcolepsy Treatment Market

The global narcolepsy treatment market size was estimated at USD 3.2 Bn in 2021, growing at a CAGR rate of 9.9% during the forthcoming years 2022-2028.

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Global Narcolepsy Treatment Market By Type of Disorder (Secondary Narcolepsy, Narcolepsy with cataplexy, Narcolepsy without cataplexy), By Drugs (Amphetamines, Methylphenidate, Modafinil, MAO-B Inhibitors (Selegiline), Tricyclic Anti-Depressants (TCA), Selective Serotonin Reuptake Inhibitors (SSRI), Monoamine Oxidase Type-A (MAO-A) inhibitors), By Distribution Channel (Hospital pharmacies, Retail Pharmacies, Online Pharmacies) and Geography (North America, Europe, Asia-Pacific, South America and, The Middle East & Africa) - Global/Region/Country Forecast to 2028."

View the detailed Report Description here - https://precisionbusinessinsights.com/market-reports/global-narcolepsy-treatment-market/

Growing demand for advanced diagnostics and therapeutics to treat sleeping disorders bolsters the Global Narcolepsy Treatment Market:
Narcolepsy is a disabling condition characterized by symptoms like fluctuating automatic behaviors, excessive daytime cataplexy and irresistible sleep and sleepiness. It is a lifelong sleeping disorder makes person feel very tired and sometimes with uncontrollable sudden sleep attacks in severe cases. It is the third most common sleeping disorder affects the bigger population group. This disorder is not curable however can be treated with the use of drugs like methylphenidate and dextroamphetamine. These drugs are also given to reduce the sleep attacks. Market players focus on adopting strategies such as collaborations, expansions to untapped geographies, acquisitions and mergers to improve product portfolio and enhance the growth of market. Narcolepsy usually starts between 15 to 25 years and it may be evident at any age.

Factors that are impelling the global narcolepsy treatment market are growing consciousness regarding the sleep disorders and increase in the prevalence of different sleeping disorders including narcolepsy. Moreover, growing ageing population and increase in the demand for advanced diagnostics and therapeutics for treating sleeping disorders also contribute to the growth of the market. A narcoleptic disorder is proportionately prevalent to the Parkinson's disease. More than 3 million people are suffering from narcolepsy around the globe according to the WHO statistics. But, the misuse of drugs, strict regulatory framework, undiagnosed of the narcolepsy and unawareness regarding the disorder in underdeveloped economies are the factors hindering the narcolepsy treatment market growth.

Europe accounted for major share in Narcolepsy Treatment Market:
On the basis of regional analysis, global narcolepsy treatment market is categorized into leading regions such as North America, Europe, Latin America, Asia Pacific, Middle East and Africa. Established healthcare infrastructure existence associated with larger population target, increase in the prevalence of narcolepsy disorder and growing capital investments are the factors fuel the Europe narcolepsy treatment market. North America witnesses considerable market share in narcoleptic treatment market due to the increase in the prevalence of the narcolepsy. Roughly 1 in 2,000 people in U.S. are suffering from narcolepsy according to Narcolepsy Network. The prevalence of disorder is about 0.07% in North America.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16872

Competitive Analysis - Global Narcolepsy Treatment Market:
A few major players working in the global narcolepsy treatment market are Arena Pharmaceuticals, Inc.(U.S), BIOPROJET, Evotec AG (Germany), Graymark Healthcare, Inc. (U.S), Hypnion, Inc. (U.S), Ligand Pharmaceuticals, Inc.(U.S), Teva Pharmaceutical Industries Ltd.(Israel) and Jazz Pharmaceuticals, Inc.,(Ireland).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.